Apnar Pharma LLP

FDA Regulatory Profile

Apnar Pharma LLP has 0 FDA recalls, 4 inspections, 0 510(k) clearances and 0 compliance actions on record.

Latest inspection
May 22, 2026 · VAI

Reviewing Apnar Pharma LLP as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Apnar Pharma LLP yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections4Nov 8, 2026Newest record Oct 28, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Recent FDA Inspections

DateSiteProductClassificationFEI
May 22, 2026East Windsor, NJDrugsVoluntary Action Indicated (VAI)3011136472
Aug 16, 2024Chino, CADrugsNo Action Indicated (NAI)3023702739
Sep 1, 2022East Windsor, NJDrugsNo Action Indicated (NAI)3011136472
Jul 10, 2015East Windsor, NJFood/CosmeticsVoluntary Action Indicated (VAI)3011136472

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3011136472East Windsor, NJ3May 22, 2026
FEI 3023702739Chino, CA1Aug 16, 2024

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.